Redeye comments on Cantargia’s Q3 report, the proposed rights issue of SEK170m and the plans to focu...
Redeye provides a research update following the Q3 report published by OncoZenge earlier today.
Some positive signs in Germany, but market still weak '25e-'26e EBIT raised by 11-12%, driven by Ger...
Redeye updates on Better Collective post Q3-results, where we have made limited changes to our estim...
Redeye updates its estimates following the Q3 2024 report from Precise Biometrics.
Redeye updates its estimates following CTEK’s Q3 report, which was better than we expected.
Redeye saw a report with sales that were lower than our expectations.
Redeye updates its estimates and valuation following Navigo releasing its Q3 2024 report.
Redeye comments on the announcement that the current CEO has left.
Minor Q3 miss but strong YTD performance Strong balance sheet, ready to act on opportunities Fair va...
Irisity AB (“Irisity” or “the Company”) is a leading provider of AI-driven video analytics solutions...
Train Alliance redovisade intäkter på 70,5 MSEK för Q3 2024, främst från projektförsäljningar, med e...
Pharma Equity Group (“PEG” or “the Company”) published its Q3 report for 2024 on the 15th of Novembe...
Dala Energi just press-released the outcome of the extra general Leksand meeting.
Trots ett fortsatt tufft marknadsläge även under tredje kvartalet lyckades Elon upprätthålla ett pos...
Angler Gaming plc (”Angler Gaming” eller ”Bolaget”) levererade en kv3 2024-rapport över vår förvänta...
Redeye states that while Automotive sales came in as expected, Behavioral Research’s unexpectedly we...
Creditas, som utgör cirka 50% av VEFs investeringsportfölj, kom med en urstark Q3-rapport.
Redeye provides further commentary on the Indian tax authorities’ visit to Truecaller’s India office...
Redeye provides an initial take on the Q3 2024 report from Precise Biometrics, which is to be consid...
